South Korea Vaccines Market to 2032
Overview
The South Korea Vaccines Market is expected to reach a 1,712.15 USD Billion by 2032 and is projected to grow at a CAGR of 13.10% from 2025 to 2032.
Revenue, 2024 (USD Billion)
877.77
Forecast, 2032 (USD Billion)
1,712.15
CAGR, 2024 - 2032
13.10%
Report Coverage
South Korea
South Korea Vaccines Market 2018-2032 USD Billion
South Korea Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 877.77 USD Billion
- Projected Market Size (2032): 1,712.15 USD Billion
- CAGR (2025-2032): 13.10%
Key Findings of South Korea Vaccines Market
- The South Korea Vaccines Market was valued at 877.77 USD Billion in 2024.
- The South Korea Vaccines Market is likely to grow at a CAGR of 13.10% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 784.32 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 15.00% during the forecast period from 2024 to 2032.
South Korea Vaccines Market Scope
South Korea Vaccines Market Segmentation & Scope
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Route of Administration
- Nasal
- Oral
- Injectable
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
South Korea Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 877.77 USD Billion |
| Market Value in 2032 | 1,712.15 USD Billion |
| CAGR (2025-2032) | 13.10% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Composition,Kind,Route of Administration,Diseases,End User,Distribution Channel,Age of Administration |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 877.77 USD Billion in 2024
- Key Country: South Korea, leading in terms of revenue with value of 877.77 USD Billion in 2024.
Segments and Scope
-
South Korea Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 349.09 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 13.83 % in forecast period 2025-2032.
-
South Korea Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 677.44 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 13.39 % in forecast period 2025-2032.
-
South Korea Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 594.21 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 12.61 % in forecast period 2025-2032.
-
South Korea Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 784.32 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 13.17 % in forecast period 2025-2032.
-
South Korea Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 142.18 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 14.27 % in forecast period 2025-2032.
-
South Korea Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 543.45 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 12.86 % in forecast period 2025-2032.
-
South Korea Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 568.40 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 12.54 % in forecast period 2025-2032.
-
South Korea Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in South Korea Vaccines Market to 2032 with a revenue of 515.99 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in South Korea Vaccines Market to 2032 with a Growth rate of 12.85 % in forecast period 2025-2032.
South Korea Vaccines Market Company Share Analysis
South Korea Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
South Korea Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Vaccines Market is segmented based on Segmentation Type,Composition,Kind,Route of Administration,Diseases,End User,Distribution Channel,Age of Administration.
South Korea Vaccines Market was valued at USD 877.77(Revenue in USD Billion) in 2020.
South Korea Vaccines Market is projected to grow at a CAGR of 13.10% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the South Korea Vaccines Market, holding a largest market share of 784.32 USD Billion in 2024
Coming Soon....
South Korea Vaccines Market Scope
South Korea Vaccines Market Segmentation & Scope
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Route of Administration
- Nasal
- Oral
- Injectable
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Frequently Asked Questions
The South Korea Vaccines Market is segmented based on Segmentation Type,Composition,Kind,Route of Administration,Diseases,End User,Distribution Channel,Age of Administration.
South Korea Vaccines Market was valued at USD 877.77(Revenue in USD Billion) in 2020.
South Korea Vaccines Market is projected to grow at a CAGR of 13.10% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Vaccines Market for final year is USD 1,712.15 (USD Billion).
South Korea Vaccines Market Company Profiling
Frequently Asked Questions
The South Korea Vaccines Market is segmented based on Segmentation Type,Composition,Kind,Route of Administration,Diseases,End User,Distribution Channel,Age of Administration.
South Korea Vaccines Market was valued at USD 877.77(Revenue in USD Billion) in 2020.
South Korea Vaccines Market is projected to grow at a CAGR of 13.10% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Vaccines Market for final year is USD 1,712.15 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.